Radiopharm Theranostics Ltd ADR RADX 深 滬
等待開盤 12-11 09:30:00 美东时间
4.28
+0.050
+1.18%
華盛通- 最 高4.28
- 今 開4.25
- 成交量 6.64万股
- 最 低 3.62
- 昨 收 4.23
- 總市值 3374.01万
- 52周最高 11.00
- 市盈率 靜 --
- 換手率 0.84%
- 52周最低 3.4962
- 委 比 -55.56%
- 總股本 788.32万
- 歷史最高 50.82
- 量 比 5.04
- 振 幅 15.60%
- 歷史最低 3.4962
- 每 手 1
- 風險率 0.85%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Radiopharm Theranostics Announces Change in Substantial Holder Status
An update from Radiopharm Theranostics Limited ( ($AU:RAD) ) is now available. ...
12-10 09:07
Radiopharm Theranostics Limited Holdings Concentration Revealed
The latest announcement is out from Radiopharm Theranostics Limited ( ($AU:RAD)...
12-09 08:18
Radiopharm Theranostics Announces Director Departure
The latest update is out from Radiopharm Theranostics Limited ( ($AU:RAD) ). Ra...
11-25 14:28
Radiopharm Theranostics Highlights Key Investor Considerations at AGM
Radiopharm Theranostics Limited ( ($AU:RAD) ) has issued an announcement. Radio...
11-20 07:10
Radiopharm Theranostics Appoints New Director
The latest update is out from Radiopharm Theranostics Limited ( ($AU:RAD) ). Ra...
11-19 13:57
Radiopharm Theranostics Completes Enrollment For Second Group Of Participants In Phase 1 Dose Escalation Study Of 177Lu-RAD204 In PD-L1 Positive Advanced Cancers
Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, "Radiopharm" or the "Company"), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical
11-12 21:36
Radiopharm Theranostics to Present at Deutsche Bank ADR Virtual Investor Conference
The latest update is out from Radiopharm Theranostics Limited ( ($AU:RAD) ). Ra...
11-03 10:37
Radiopharm Theranostics Director Increases Shareholding
Radiopharm Theranostics Limited ( ($AU:RAD) ) has issued an update. Radiopharm ...
11-03 09:47
Radiopharm Theranostics Advances with Promising PD-L1 Targeted Therapy Study
Radiopharm Theranostics Limited (($AU:RAD)) announced an update on their ongoin...
10-28 01:59
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Replimune Group (NASDAQ:REPL) stock increased by 95.3% to $8.79 during...
10-20 20:08
